✦ LIBER ✦

PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

✍ Scribed by R.C. Adams; C. Walsh; S. Schmitz; P. Barton; M. Barry

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS7 COST ANALYSIS OF RECENTLY APPROVED

✍ C Carter; C Schmeichel-Mueller; RS McKenzie; CT Piech 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS28 COST-EFFICACY ANALYSIS OF TNF ALPH

✍ Gil-Hurlé A Dominguez; Ruiz M Costi; Sien C Campo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB

✍ V Brodszky; M Péntek; K Karpati; I Boncz; A Sebestyén; L Gulácsi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Treatment of rheumatoid arthritis with a

✍ Roberto Caporali; Francesca Bobbio Pallavicini; Matteo Filippini; Roberto Gorla; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 239 KB

PMS31 Cost-Effectiveness Analysis of Gol

✍ R.J. Desai; J. Rao; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS49 COST-UTILITY ANALYSIS OF LEFLUNOMI

✍ Plisko, R; Krzystek, J; Lis, J; Rys, P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB